PRKCD and neoplasm: The results showed that PRKCD not only modulated the malignant behaviors of tumor cells but also participated in the regulation of platelet activation, indicating that PRKCD acted as a key mediator in the cross-talk between HCC cells and platelets, and targeting PRKCD might be a hopeful intervention mean for the treatment of HCC.